Oxalate-Linked Electrochemistry Enables Early Detection of Sclerotinia Blight in Peanut Crops Using 3D-Printed Nanostructured Pt Sensors

Abstract

Abstract Sclerotinia minor (causing Sclerotinia blight) is a devastating pathogen in peanut production, with severe outbreaks causing up to 50% yield loss due to rapid oxalic acid (OA) accumulation. Early diagnosis is challenging because canopy-level symptoms typically emerge only after infection is well established, while early cues are subtle, stem-localized, and nonspecific; in contrast, molecular assays are time- and resource-intensive. Despite established mechanistic links between oxalate accumulation and disease progression, so far, there are no sensors developed or tested for detecting Sclerotinia blight in peanut plants. This paper reports a low-cost, lithography-free, and label-free electrochemical sensor for metabolite-targeted, presymptomatic monitoring of S. minor in peanut plants based on clear mechanistic links between oxalate accumulation and disease progression. The sensor platform comprises 3D-printed resin substrates with platinum (Pt) electrodes and a nanostructured reduced graphene oxide (rGO)−chitosan interface functionalized with an oxaloacetic acid (OAA) interfacial layer. Using ferri/ferrocyanide as a redox probe, the sensor exhibited a linear calibration to oxalate (prepared from OA) from 0.05 µM to 1 mM (R2 = 0.99), with a sensitivity of 6.37 µA/decade, limit of detection of 17.6 nM, and excellent coefficient of variation of 0.93−3.32% across standards (n = 4). In real plant trials, stem sap from S. minor-inoculated peanut plants produced significantly elevated voltammetric responses relative to healthy and Nothopassalora personata controls as early as five days post-inoculation (dpi), enabling longitudinal monitoring through 20 dpi (p

Plant phenotyping relevance

植物体内のシュウ酸を指標に、ピーナッツの病害を早期・無症状段階で検出する電気化学センサーを開発し、校正性能と実植物での識別・経時モニタリングを検証している。病害状態の取得法が研究の中心である。

Code and data availability

公開論文であることは確認できましたが、現在の公式API・許可済み取得経路では本文を自動取得できませんでした。

No evidence-backed public reproduction asset is currently recorded.